The Bar Council of India does not permit advertisement or solicitation by advocates in any form or manner. By accessing this website, www.khaitanco.com, you acknowledge and confirm that you are seeking information relating to Khaitan & Co of your own accord and that there has been no form of solicitation, advertisement or inducement by Khaitan & Co or its members. The content of this website is for informational purposes only and should not be interpreted as soliciting or advertisement. No material/information provided on this website should be construed as legal advice. Khaitan & Co shall not be liable for consequences of any action taken by relying on the material/information provided on this website. The contents of this website are the intellectual property of Khaitan & Co.

Please accept the above


See all results for ""
Kartick Maheshwari

Kartick Maheshwari

, Mumbai

Partner | Private Equity, Restructuring and Insolvency, Mergers and Acquisitions


  • LL.M, University of Pennsylvania Law School
  • B.A., LL.B (Hons), National Law School of India University, Bengaluru

Kartick Maheshwari represents private equity firms, sovereign wealth funds and corporate strategic investors in a range of transactions in the healthcare, real estate, financial services, e-commerce and consumer sectors. This has included transactions involving complex restructurings and workouts in India.

He has been highly involved in several recent advisory mandates relating to Indian distressed assets and in particular has been advising several hedge funds and UHNI families on the new Indian insolvency regulations, acquisition of distressed loan portfolios and general enforcement related strategy.

Kartick also actively engages with Indian regulators on policy matters – not just when it comes to pushing a client agenda, but also when it comes to simplicity and efficiency in rule making. 

Prior to joining Khaitan & Co as a partner in 2014, Kartick was part of the corporate practice at a large international firm. 

Recognition and Accomplishment

  • Recognised by Chambers & Partners (2020) as an Up & Coming private equity practitioner. The client feedback published by Chambers was “bright, pragmatic and deal-oriented”.
  • Featured in the 40 Under 40 list of Asia Legal Business (Thomson Reuters), which recognises 40 outstanding lawyers in the region under the age of 40.
  • Listed as an “Emerging Leader in India” by RSG’s 2019 market survey
  • Recognised as a Notable Practitioner for his expertise in the Private Equity and Mergers & Acquisitions space by IFLR 1000.

Representative Matters

Kartick Maheshwari has represented and advised the following clients

Apax Partners

Advised Apax Partners on the sale of a controlling stake held by Apax in the Healthium Group, to a special purpose vehicle owned by KKR.


Advised various TPG platforms (TPG Capital, TPG Growth, TPG NewQuest) on transactions across sectors such as IT services, consumer, financial services.


GCC Sovereign Wealth Fund

Advised a GCC sovereign wealth fund on various investment in India in the financial services and health care sector.


Cerberus Capital Management

Advised Cerberus Capital Management and Canyon Capital Advisors LLC on their investment in the Shapoorji Pallonji Group.

CarVal Investors

Advised CarVal Investors in their acquisition of Uttam Galva Metallics Limited and Uttam Value Steel Ltd.


Advised Pinebridge on exits from various legacy positions in India - Maini Precision, SKIL Infrastructure, Narayana Hrudayalaya.


Advised Haier on the acquisition of the GE India business.

India Resurgence Fund

Advised India Resurgence Fund (IndiaRF) in the acquisition of Ind-Swift Laboratories Ltd.’s active pharmaceutical ingredients and contract research and manufacturing services business by its portfolio company, Synthimed Labs for INR 1,650 crore.

Maj Invest

Advised Maj Invest on their investments in various financial services businesses in India.

Reliance Industries Limited

Advised Reliance Industries Limited and Viacom18 Media Private Limited on its strategic joint venture with The Walt Disney Company.

Famy Care Group

Advised the Famy Care Group / Taparia Family on their pharma exit transactions with Viatris.

Similar profiles